Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DGCR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ROCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PHTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927829 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLRP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDH10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC283585 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNJ15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507376 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1GALT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIPA1L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIPA1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100240728 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ING3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on